What will be Briumvi's sales revenue in 2025? | Categorical | | | 2 months ago | |
Will Briumvi receive FDA approval for additional indications by end of 2024? | Binary | | | 2 months ago | |
Will TG Therapeutics secure a partnership or acquisition deal by mid-2025? | Binary | | | 2 months ago | |
Will Briumvi surpass Ocrevus in market share for MS treatments by 2025? | Binary | | | 2 months ago | |
Will BRIUMVI receive FDA approval for 30-minute infusion treatment by end of 2024? | Binary | | | 3 months ago | |
By what percentage will TG Therapeutics' stock price increase by end of 2024? | Categorical | | | 3 months ago | |
What will be Briumvi's market share in MS treatment by end of 2025? | Categorical | | | 2 months ago | |
Which company will be the next major competitor in MS treatments by 2025? | Categorical | | | 2 months ago | |
Which regulatory bodies will approve BRIUMVI by end of 2024? | Categorical | | | 3 months ago | |
Will BRIUMVI reach 50% market share among CD20 treatments by September 2025? | Binary | | | 3 months ago | |
Will BRIUMVI maintain an annualized relapse rate of 0.020 in the 6th year of treatment by end of 2025? | Binary | | | 3 months ago | |
How many patients will be on BRIUMVI treatment by September 2025? | Categorical | | | 3 months ago | |
